Skip to main content

Table 2 Correlations between the expression level of Bmi-1 or Mel-18 and clinical-pathologic variables

From: Expression and clinicopathological significance of Mel-18 and Bmi-1 mRNA in gastric carcinoma

Variable Bmi-1 Mel-18
  n GA P n GA P
Gender       
   Male 58 1.568 0.687 58 0.259 0.309
   Female 13 1.958   13 0.150  
Age(years)       
   <60 44 1.584 0.832 44 0.188 0.166
   ≥60 27 1.715   27 0.336  
Size (cm)       
   <4.5 26 0.965 0.049* 26 0.206 0.335
   ≥4.5 45 2.213   45 0.313  
Histology       
   Moderately differentiated 13 0.989 0.248 13 0.185 0.584
   Poorly differentiated 58 1.827   58 0.247  
T classification       
   T1/2 12 0.635 0.036* 12 0.399 0.242
   T3/4 59 1.979   59 0.210  
LNM       
   Negative 16 0.762 0.044* 16 0.513 0.037*
   Positive 55 2.038   55 0.186  
Distant metastasis       
   Negative 68 1.663 0.597 68 0.232 0.645
   Positive 3 2.932   3 0.372  
Clinical Stage       
   I/II 22 0.949 0.075 22 0.506 0.010*
   III/IV 49 2.084   49 0.166  
  1. Abbreviations: LNM, lymph node metastases; GA, geometrical average; *, Statistically significant. Statistically significant at 0.05 level (bilateral).